Solara Active Pharma Sciences Limited
Stock Forecast, Prediction & Price Target
Solara Active Pharma Sciences Limited Financial Estimates
Solara Active Pharma Sciences Limited Revenue Estimates
Solara Active Pharma Sciences Limited EBITDA Estimates
Solara Active Pharma Sciences Limited Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | 3/31/2027 | ||
Revenue
% change YoY
| ₹15.75B N/A | ₹12.30B -21.90% | ₹12.38B 0.63% | Avg: ₹17.81B Low: ₹17.81B High: ₹17.81B avg. 43.83% | Avg: ₹18.90B Low: ₹18.90B High: ₹18.90B avg. 6.12% | ||
Net Income
% change YoY
| ₹2.21B N/A | ₹-581.5M -126.26% | ₹-5.67B -875.73% | Avg: ₹942M Low: ₹765.53M High: ₹765.53M avg. 116.60% | Avg: ₹1.11B Low: ₹1.11B High: ₹1.11B avg. 18.16% | ||
EBITDA
% change YoY
| ₹4.13B N/A | ₹1.04B -74.72% | ₹-2.82B -369.75% | Avg: ₹2.12B Low: ₹2.12B High: ₹2.12B avg. 175.25% | Avg: ₹2.25B Low: ₹2.25B High: ₹2.25B avg. 6.12% | ||
EPS
% change YoY
| $69 N/A | -$16.18 -123.44% | -$145.27 -797.83% | Avg: $19.6 Low: $19.6 High: $19.6 avg. 113.49% | Avg: $28.5 Low: $28.5 High: $28.5 avg. 45.40% | ||
Operating Expenses
% change YoY
| ₹5.25B N/A | ₹5.50B 4.62% | ₹3.99B -27.29% | Avg: ₹1.78B Low: ₹1.78B High: ₹1.78B avg. -55.28% | Avg: ₹1.89B Low: ₹1.89B High: ₹1.89B avg. 6.12% |
FAQ
What is Solara Active Pharma Sciences Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 67.38% in 2026-2027.
We have gathered data from 1 analysts. Their low estimate is 765.53M, average is 942M and high is 765.53M.
What is Solara Active Pharma Sciences Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 24.98% in 2026-2027.
We have gathered data from 1 analysts. Their low revenue estimate is ₹17.81B, average is ₹17.81B and high is ₹17.81B.
What is Solara Active Pharma Sciences Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 79.45% in 2026-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is $19.6, average is $19.6 and high is ₹19.6.